1154 - Facility level variation in rates of definitive therapy for low risk prostate cancer among men with limited life expectancy: An opportunity for value-based care redesign

Autor: Von Landenberg, N., Cole, A., Friedlander, D., Berg, S., Löppenberg, B., Noldus, J., Roghmann, F., Kibel, A., Trinh, Q.-D.
Zdroj: In European Urology Supplements March 2018 17(2):e1626-e1627
Databáze: ScienceDirect